‘Welcome news’: TGA green-lights first endometriosis treatment in a decade
Associate Professor Magdalena Simonis says it is an ‘important addition’ to options such as laparoscopy.
The TGA has green-lit a new endometriosis medication for the first time in 13 years, expanding the indication of a combination pill used to treat uterine fibroid symptoms.
The once daily pill contains GnRH antagonist relugolix 40mg with estradiol 1mg and norethisterone 0.5mg.
